Implanet has been granted CE mark for its new Jazz Standalone implant, used in the treatment of adult degenerative bone disorders.
The device is designed to offer fast and simple freestanding posterior fixation to replace traditional fixation systems. It can be incorporated in the JAZZ product range without new investments in equipment or training for surgical teams, a company release states.
Régis Le Couedic, Implanet’s Product Development & Manufacturing Director, says: “The Jazz Standalone is a new variant of our Jazz technology devoted to treating degenerative pathologies. This implant utilises the Jazz Band platform, and is intended to enable vertebral segments to be stabilised without the need for pedicle screws and rods.”
